Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing

Chronic myeloid leukemia in blast crisis (CML BC) remains a challenging disease to treat despite the introduction and advances in tyrosine kinase inhibitor (TKI) therapy. In this study we set out to identify novel candidate drugs for CML BC by using an unbiased high-throughput drug testing platform....

Descripción completa

Detalles Bibliográficos
Autores principales: Pietarinen, P O, Pemovska, T, Kontro, M, Yadav, B, Mpindi, J P, Andersson, E I, Majumder, M M, Kuusanmäki, H, Koskenvesa, P, Kallioniemi, O, Wennerberg, K, Heckman, C A, Mustjoki, S, Porkka, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423219/
https://www.ncbi.nlm.nih.gov/pubmed/25933373
http://dx.doi.org/10.1038/bcj.2015.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423219/
https://www.ncbi.nlm.nih.gov/pubmed/25933373
http://dx.doi.org/10.1038/bcj.2015.30

Ejemplares similares